openPR Logo
Press release

Advance Drug Discovery with Creative Biolabs' High-Throughput Screening Solutions

11-26-2024 07:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: PRChoices
Advance Drug Discovery with Creative Biolabs' High-Throughput

Creative Biolabs uses advanced innovative technology to accelerate drug discovery and research in target-specific therapy for a wide range of diseases, including cancer, genetic disorders, and infectious diseases.
New York, USA - November 25, 2024 - In recent years, the field of RNA therapeutics has emerged as a revolutionary area in biotechnology, offering promising avenues for the treatment of a multitude of diseases, including cancer, genetic disorders, and infectious diseases. Furthermore, as more and more becomes understood about the biology of RNA, its potential for gene therapy becomes obvious, resulting in growing attention by the academic and pharmaceutical sectors. Creative Biolabs has modern services and technologies that assist in the creation of cell therapeutics based on RNA. They focus on high-throughput screening techniques that allow for rapid identification of effective RNA molecules, streamlining the drug discovery process.

Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg

SiRNA technology forms an inseparable section of genetics that enables the silencing of cellular regulation mechanisms. Creative Biolabs provides services and capabilities for siRNA screening [https://www.creative-biolabs.com/gene-therapy/sirna-in-vitro-screening-service.htm], which will help select the best siRNA sequences that will downregulate targeted genes most efficiently.

"High-throughput screening in our facility allows us to discover and confirm effective siRNA-modified targets in a timeous manner," said a scientist from this company. "We assist researchers all over the world to carry out their siRNA-based projects and to achieve results that include screening and functional and kinetic analysis of the chosen targets."

Antisense oligonucleotides (ASOs) can be designed to treat a broad range of genetic diseases. Creative Biolabs assists researchers by providing ASO Screening [https://www.creative-biolabs.com/gene-therapy/aso-in-vitro-screening-service.htm] services that allow them to design suitable ASO sequences for gene expression modulation. Enhanced screening technologies allow the development of AO therapeutics with relative ease, precision and efficacy. From sequence design to acquisition of AO with desired anti-sense activity, their practice provides expertise in all aspects of ASO development.

In addition to RNA-based solutions, Creative Biolabs has wide experience in aptamer design [https://www.creative-biolabs.com/gene-therapy/custom-aptamer-design-service-for-rnai.htm] and provides custom solutions to fit the specific requirements of each project.

"Aptamers are molecular tools that are specially engineered for use in diagnostics, therapeutics, and other areas. Our patented aptamer selection and optimization procedures ensure the discovery of aptamers with excellent affinity and specificity. With our expertise, researchers are in a position to design aptamers that bind selectively to specific types of molecules," emphasized the scientist.

As a trusted partner in therapeutics development, Creative Biolabs is dedicated to offering innovative and tailored solutions for our customers to ensure the effects of their projects. Their mission is to provide strong support to customers' research projects with expertise and cutting-edge development platforms.

Learn more information about services regarding RNA therapeutics research, please visit https://www.creative-biolabs.com/gene-therapy.

About Creative Biolabs

Creative Biolabs is a biotechnology company based in US, focusing on the development of efficient solutions for biomedical studies and drug discovery and development. With the commitment to advancing RNA therapeutics, the company delivers siRNA screening, ASO screening, and aptamer design services to enhance customers' research projects for new therapies.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=advance-drug-discovery-with-creative-biolabs-highthroughput-screening-solutions]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/gene-therapy



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advance Drug Discovery with Creative Biolabs' High-Throughput Screening Solutions here

News-ID: 3757428 • Views:

More Releases from Getnews

Manhattan Elderly Care Tackles Top Senior Worries Through Guided Active Aging from Touching Hearts at Home NYC
Manhattan Elderly Care Tackles Top Senior Worries Through Guided Active Aging fr …
Image: https://www.globalnewslines.com/uploads/2025/09/1757439777.jpg A compassionate intentional approach helps NYC seniors age at home safely while enjoying autumn activities and combating isolation during Active Aging Week NEW YORK, NY - September 15, 2025 - A recently published study from the New York City Department for the Aging reveals a pressing urban health crisis: over 25% of the city's seniors live alone, a primary driver of an isolation epidemic that the National Institute on Aging
Inspire Ambitions Unveils New Report Showing Graduate Expectation Gap in the UAE Workforce
Inspire Ambitions Unveils New Report Showing Graduate Expectation Gap in the UAE …
Inspire Ambitions launches "The 2025 Graduate Expectation Gap Report," highlighting disconnects between student career expectations and workplace realities. Image: https://www.globalnewslines.com/uploads/2025/09/6f6df43eab6fb7f22996fcc669a39629.jpg A new report released today by Inspire Ambitions [https://inspireambitions.com/], The 2025 Graduate Expectation Gap Report [https://inspireambitions.com/product/from-campus-to-career/], reveals that a significant majority of recent graduates in the UAE feel unprepared for the realities of today's workplace. The findings shed light on a widening divide between university preparation and the skills needed to succeed
Future Electronics and Infineon to Host Free Webinar on Next-Generation Smart HMI Design with PSOC Trademark Edge
Future Electronics and Infineon to Host Free Webinar on Next-Generation Smart HM …
Image: https://www.globalnewslines.com/uploads/2025/09/1757697276.jpg Future Electronics & Infineon's free webinar on Sept 25 to explore how PSOC Trademark Edge powers next-gen smart HMIs with AI, voice & gesture control. Montreal, Canada - September 12, 2025 - Future Electronics, a leading global distributor of electronic components, is pleased to announce an upcoming free webinar hosted in collaboration with Infineon Technologies: Unlock Innovation with PSOC Trademark Edge for Next-Gen Smart HMIs. The live session will take place
RoadMap Advisors Enhances Sell-Side M&A Services for Middle Market Business Owners
RoadMap Advisors Enhances Sell-Side M&A Services for Middle Market Business Owne …
Image: https://www.globalnewslines.com/uploads/2025/09/1757662626.jpg RoadMap Advisors, a Virginia-based consulting firm, has refined its sell-side M&A service offerings to provide greater process efficiency, buyer alignment, and transaction readiness for business owners seeking full or partial exits. Vienna, VA - September 12, 2025 - RoadMap Advisors, a leading consulting firm in Tysons, VA [https://www.roadmapadvisors.com/], has announced the refinement of its sell-side mergers and acquisitions (M&A) services [https://www.roadmapadvisors.com/mergers-acquisitions/sell-side/], incorporating a structured, advisor-led process designed to help business

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may